Reporting owner · CIK 0001662982

Wang Xiaodong

Visual SEC Form 4 history across 2 companies, 25 transactions and 3 filings.

DIRBeOne Medicines Ltd.
Open-market mix
Latest filingSep 10, 2026, 08:49 PM
Filings3Form 4 records
Buying$00 purchases
Selling$30.2M19 sales
Net value−$30.2MBuys minus sells
Companies22 securities
Most recentSep 08, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-105Jan 256Feb 258Sep 26

Net value flow

Buys minus sells

Jan 25
−$7.4M
Feb 25
−$9.4M
Sep 26
−$13.4M

Transaction texture

Ownership and ticket size

Average P/S size$1.6M
Median P/S size$1M
Direct25
Indirect0
Sep 08, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Derivative Transactionfiling-context2Direct Ownershipfiling-context15Large Holdings Increaseholdings2Large Holdings Reductionholdings8Large Salesize6Repeat Sellerpattern1010b5-1 Detectedfiling-context15

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at BeOne Medicines Ltd. on Sep 08, 2026 valued at $2,205,174.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at BeOne Medicines Ltd. on Sep 08, 2026 valued at $2,205,174.

Review SEC filing

Associated companies

Visual map of known reporting history

ONCBeOne Medicines Ltd.10 transactions · latest Sep 10, 2026, 08:49 PMBGNEBeiGene, Ltd.15 transactions · latest Feb 06, 2025, 09:44 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
BGNEWang Xiaodong
DIR
exercise10b5-1542k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—02/06/202502/04/2025
BGNEWang Xiaodong
DIR
sale10b5-11.40k-$31.9MS
Direct Ownership Repeat Seller 10b5-1 Detected
—02/06/202502/04/2025
BGNEWang Xiaodong
DIR
sale10b5-19.77k-$221MS
Direct Ownership Large Holdings Reduction Large Sale+2
—02/06/202502/04/2025
BGNEWang Xiaodong
DIR
sale10b5-117.8k-$403MS
Direct Ownership Large Holdings Reduction Large Sale+2
—02/06/202502/04/2025
BGNEWang Xiaodong
DIR
sale10b5-12.16k-$48.6MS
Direct Ownership Repeat Seller 10b5-1 Detected
—02/06/202502/04/2025
BGNEWang Xiaodong
DIR
sale10b5-11.51k-$34.0MS
Direct Ownership Repeat Seller 10b5-1 Detected
—02/06/202502/04/2025
BGNEWang Xiaodong
DIR
sale10b5-19.09k-$202MS
Direct Ownership Large Holdings Reduction Large Sale+2
—02/06/202502/04/2025
BGNEWang Xiaodong
DIR
exercise10b5-141.7k$27.1MM
Direct Ownership Large Holdings Increase 10b5-1 Detected
—02/06/202502/04/2025
BGNEWang Xiaodong
DIR
exercise10b5-1542k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
—01/08/202501/07/2025
BGNEWang Xiaodong
DIR
sale10b5-11.30k-$23.3MS
Direct Ownership Repeat Seller 10b5-1 Detected
—01/08/202501/07/2025

Wang Xiaodong Insider Activity FAQ

SEC Form 4 context

Who is Wang Xiaodong?

Wang Xiaodong is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001662982.

Which companies has Wang Xiaodong reported transactions for?

BeOne Medicines Ltd., BeiGene, Ltd.

When was Wang Xiaodong's latest insider buy?

No open-market insider purchase is available for this period.

When was Wang Xiaodong's latest insider sale?

sale at BeOne Medicines Ltd. on Sep 08, 2026 valued at $2,205,174.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.